A detailed history of Nan Shan Life Insurance Co., Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Nan Shan Life Insurance Co., Ltd. holds 1,302,657 shares of BMY stock, worth $69.3 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares
1,302,657
Previous 1,330,953 2.13%
Holding current value
$69.3 Million
Previous $72.2 Million 25.05%
% of portfolio
1.28%
Previous 1.71%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $1.14 Million - $1.5 Million
-28,296 Reduced 2.13%
1,302,657 $54.1 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $7.1 Million - $7.94 Million
122,707 Added 10.16%
1,330,953 $77.2 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $18.5 Million - $20.6 Million
290,835 Added 31.7%
1,208,246 $77.3 Million
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $21.2 Million - $24 Million
322,044 Added 54.09%
917,411 $63.6 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $39.4 Million - $46.6 Million
-574,984 Reduced 49.13%
595,367 $42.8 Million
Q3 2022

Nov 15, 2022

BUY
$0.13 - $76.84 $79,178 - $46.8 Million
609,064 Added 108.51%
1,170,351 $83.2 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $72.4 Million - $79.8 Million
-997,521 Reduced 63.99%
561,287 $43.2 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $17.5 Million - $20.4 Million
326,893 Added 26.54%
1,558,808 $97.2 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $16 Million - $18.7 Million
270,115 Added 28.08%
1,231,915 $72.9 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $18.9 Million - $20.6 Million
-305,807 Reduced 24.12%
961,800 $64.3 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $12.6 Million - $13.9 Million
219,100 Added 20.9%
1,267,607 $76.4 Million
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $8.52 Million - $9.96 Million
155,381 Added 17.4%
1,048,507 $61.7 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $8.04 Million - $10.5 Million
163,419 Added 22.4%
893,126 $57.3 Million
Q3 2019

Nov 06, 2019

SELL
$42.77 - $50.71 $299,390 - $354,970
-7,000 Reduced 0.95%
729,707 $37 Million
Q2 2019

Aug 13, 2019

SELL
$44.62 - $49.34 $89,240 - $98,680
-2,000 Reduced 0.27%
736,707 $33.4 Million
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $2.17 Million - $2.58 Million
-48,000 Reduced 6.1%
738,707 $35.2 Million
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $4.25 Million - $5.51 Million
-87,200 Reduced 9.98%
786,707 $40.9 Million
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $1.1 Million - $1.25 Million
-20,000 Reduced 2.24%
873,907 $54.3 Million
Q2 2018

Aug 13, 2018

SELL
$50.53 - $62.98 $8.08 Million - $10.1 Million
-160,000 Reduced 15.18%
893,907 $49.5 Million
Q3 2017

Jun 20, 2018

SELL
$55.23 - $63.74 $24.3 Million - $28 Million
-440,000 Reduced 29.45%
1,053,907 $67.2 Million
Q3 2016

Jun 20, 2018

BUY
N/A
590,000 Added 65.27%
1,493,907 $80.6 Million
Q2 2016

Jun 20, 2018

SELL
N/A
-351,383 Reduced 27.99%
903,907 $66.5 Million
Q1 2016

Jun 20, 2018

BUY
N/A
100,107 Added 8.67%
1,255,290 $80.2 Million
Q4 2015

Jun 20, 2018

BUY
N/A
529,463 Added 84.62%
1,155,183 $79.5 Million
Q3 2015

Jun 20, 2018

SELL
N/A
-42,280 Reduced 6.33%
625,720 $37 Million
Q2 2015

Jun 20, 2018

BUY
N/A
180,000 Added 36.89%
668,000 $44.4 Million
Q1 2015

Jun 20, 2018

BUY
N/A
162,000 Added 49.69%
488,000 $31.5 Million
Q4 2014

Jun 20, 2018

SELL
N/A
-235,506 Reduced 41.94%
326,000 $19.2 Million
Q3 2014

Jun 20, 2018

SELL
N/A
-174,713 Reduced 23.73%
561,506 $28.7 Million
Q2 2014

Jun 20, 2018

SELL
N/A
-152,781 Reduced 17.19%
736,219 $35.7 Million
Q1 2014

Jun 20, 2018

BUY
N/A
10,000 Added 1.14%
889,000 $46.2 Million
Q4 2013

Jun 20, 2018

BUY
N/A
184,000 Added 26.47%
879,000 $46.7 Million
Q3 2013

Jun 20, 2018

BUY
N/A
132,000 Added 23.45%
695,000 $32.2 Million
Q2 2013

Jun 20, 2018

BUY
N/A
563,000
563,000 $25.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Nan Shan Life Insurance Co., Ltd. Portfolio

Follow Nan Shan Life Insurance Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nan Shan Life Insurance Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Nan Shan Life Insurance Co., Ltd. with notifications on news.